论文部分内容阅读
吉非罗齐(Gemfibrozil)降低血清甘油三酯和LDL-胆固醇,增加HDL-胆固醇。冠心病一级预防试验证明,本品使血脂异常的中年患者5年心肌梗塞危险下降。
Gemfibrozil lowers serum triglycerides and LDL-cholesterol, increases HDL-cholesterol. Primary prevention of coronary heart disease test proved that this product makes the middle-aged patients with dyslipidemia 5-year risk of myocardial infarction decreased.